Manaka Sato

713 total citations
7 papers, 585 citations indexed

About

Manaka Sato is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Manaka Sato has authored 7 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Immunology and 2 papers in Cancer Research. Recurrent topics in Manaka Sato's work include RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (3 papers) and MicroRNA in disease regulation (2 papers). Manaka Sato is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (3 papers) and MicroRNA in disease regulation (2 papers). Manaka Sato collaborates with scholars based in United States. Manaka Sato's co-authors include James E. Dahlman, Melissa P. Lokugamage, Cory D. Sago, Kalina Paunovska, Fatima Z. Islam, Philip J. Santangelo, Zubao Gan, Marine Z. C. Hatit, David Loughrey and Lena Gamboa and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and ACS Nano.

In The Last Decade

Manaka Sato

7 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manaka Sato United States 7 517 85 75 69 68 7 585
Sujay Kalathoor United States 8 495 1.0× 96 1.1× 77 1.0× 52 0.8× 76 1.1× 10 599
Alejandro J. Da Silva Sanchez United States 9 457 0.9× 77 0.9× 67 0.9× 54 0.8× 62 0.9× 12 536
Zubao Gan United States 8 524 1.0× 98 1.2× 93 1.2× 54 0.8× 86 1.3× 9 574
Elisa Schrader Echeverri United States 10 560 1.1× 96 1.1× 79 1.1× 77 1.1× 86 1.3× 20 738
Mariah L. Arral United States 8 442 0.9× 103 1.2× 73 1.0× 59 0.9× 55 0.8× 14 548
Michaela Jeong South Korea 8 656 1.3× 121 1.4× 115 1.5× 75 1.1× 80 1.2× 11 816
Ester Álvarez‐Benedicto United States 6 371 0.7× 83 1.0× 73 1.0× 50 0.7× 51 0.8× 7 464
Fatima Z. Islam United States 6 362 0.7× 67 0.8× 59 0.8× 44 0.6× 61 0.9× 6 410
Rebecca L. McClellan United States 6 606 1.2× 88 1.0× 159 2.1× 43 0.6× 78 1.1× 8 653
Christopher M. Monaco United States 3 410 0.8× 50 0.6× 63 0.8× 48 0.7× 48 0.7× 5 465

Countries citing papers authored by Manaka Sato

Since Specialization
Citations

This map shows the geographic impact of Manaka Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manaka Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manaka Sato more than expected).

Fields of papers citing papers by Manaka Sato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manaka Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manaka Sato. The network helps show where Manaka Sato may publish in the future.

Co-authorship network of co-authors of Manaka Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Manaka Sato. A scholar is included among the top collaborators of Manaka Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manaka Sato. Manaka Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hatit, Marine Z. C., Curtis Dobrowolski, Melissa P. Lokugamage, et al.. (2023). Nanoparticle stereochemistry-dependent endocytic processing improves in vivo mRNA delivery. Nature Chemistry. 15(4). 508–515. 49 indexed citations
2.
Sago, Cory D., Melissa P. Lokugamage, David Loughrey, et al.. (2022). Augmented lipid-nanoparticle-mediated in vivo genome editing in the lungs and spleen by disrupting Cas9 activity in the liver. Nature Biomedical Engineering. 6(2). 157–167. 52 indexed citations
3.
Hatit, Marine Z. C., Melissa P. Lokugamage, Curtis Dobrowolski, et al.. (2022). Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles. Nature Nanotechnology. 17(3). 310–318. 93 indexed citations
4.
Gan, Zubao, Melissa P. Lokugamage, Marine Z. C. Hatit, et al.. (2020). Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligands. Bioengineering & Translational Medicine. 5(3). e10161–e10161. 59 indexed citations
5.
Lokugamage, Melissa P., Zubao Gan, Chiara Zurla, et al.. (2019). Mild Innate Immune Activation Overrides Efficient Nanoparticle‐Mediated RNA Delivery. Advanced Materials. 32(1). e1904905–e1904905. 94 indexed citations
6.
Sago, Cory D., et al.. (2018). Nanoparticles That Deliver RNA to Bone Marrow Identified by in Vivo Directed Evolution. Journal of the American Chemical Society. 140(49). 17095–17105. 108 indexed citations
7.
Paunovska, Kalina, Carmen J. Gil, Melissa P. Lokugamage, et al.. (2018). Analyzing 2000 in Vivo Drug Delivery Data Points Reveals Cholesterol Structure Impacts Nanoparticle Delivery. ACS Nano. 12(8). 8341–8349. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026